Novartis receives Investment Bank Analyst Rating Update
Investing.com - European stock markets drifted lower Tuesday, with losses in the banking sector weighing ahead of the start of big tech earnings season on Wall Street. At 04:05 ET...
Investing.com - European stock markets are expected to open with small losses Tuesday, with investors cautious ahead of the start of big tech earnings season on Wall Street. At...
US futures and European stocks rally with cyclicals US stocks enjoyed the strongest day since March yesterday Bitcoin recovers Key EventsUS futures on the Dow, S&P, NASDAQ and...
Vanguard exchange-traded funds are among the most popular ETFs. Known for their high intraday liquidity, low expense ratios and transaction costs, these funds can be especially...
Investor hopes for the reopening of local economies buoyed as governments plan to relax lockdowns Big week for corporate earnings continues Oil takes a hit as biggest ETF dumps...
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
|Average||107.8474 (+20.6752% Upside)|
|No. of Analysts||18|
|Moving Averages||Buy||Buy||Buy||Buy||Strong Buy|
|Technical Indicators||Strong Sell||Strong Sell||Strong Sell||Strong Sell||Strong Buy|